Latest Ratings for LXRX
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jan 2021 | Wedbush | Downgrades | Outperform | Neutral |
| Jan 2021 | JP Morgan | Upgrades | Underweight | Neutral |
| Dec 2020 | Citigroup | Upgrades | Neutral | Buy |
Lexicon Pharmaceuticals Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
